Johnson & Johnson (JNJ) has submitted a new application to the U.S. FDA to expand the use of Stelara (ustekinumab) for ...

Skyrizi and Rinvoq sold nearly seven billion dollars, almost half of the company’s income for the quarter alone.

For the third straight quarter, AbbVie has jacked up its revenue forecast for 2025. The Illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. | ...

The group of lifelong intestinal conditions known as inflammatory bowel disease (IBD), which includes Crohn's disease and ...

The Department for Work and Pensions (DWP) has shared the most common gastrointestinal conditions reported on successful ...

A group of migrant workers in the United States on Friday castigated the Philippine Embassy in Washington for supposedly ...

Antibiotics have been the workhorses of modern medicine, but their success has fueled a dangerous rise in drug-resistant ...

Experts recommend eating foods high in probiotics before taking a supplement for weight loss, but supplements can help fill ...

With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...

A flyer in support of immigrant rights is taped to a pole outside of the Edge at Lowry apartment complex in Aurora, Colorado —PHOTO BY JASON CONNOLLY/AGENCE FRANCE-PRESSE MANILA, Philippines ...

In patients with inflammatory bowel disease, severe gastrointestinal infections may trigger disease flares, requiring ...

This includes capturing roughly 50% of newer switching Crohn's patients across all lines of therapy in The U.S. We see ...